Randy Schreckhise

Randy is a biotech finance and operations professional with over 20 years of experience. He has made contributions to a number of approved therapeutics and therapeutic candidates through finance, business development, operations and strategy roles at Artelo Biosciences, aTyr Pharma, Abilita Bio, Trius Therapeutics, Ardea Biosciences, Human Genome Sciences and ZymoGenetics. Prior to business school, he worked in project management, protein biochemistry, and genetics. Randy received an MBA with a concentration in finance from Seattle University and a BS in microbiology with a minor in molecular biology from Washington State University, where he was a Howard Hughes Undergraduate Research Fellow.